Drug Discovery Technologies - Global Strategic Business Report

The global market for Drug Discovery Technologies is estimated at US$69.1 Billion in 2023 and is projected to reach US$124.2 Billion by 2030, growing at a CAGR of 8.7% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

The growth in the drug discovery technologies market is driven by several factors, including the urgent need for new medical treatments, advancements in technology, and increased funding and investment in R&D by pharmaceutical companies and governments. The rising prevalence of chronic and infectious diseases worldwide demands faster and more efficient development of effective drugs.

Technological advancements that offer enhanced capabilities and efficiencies in discovering new drugs are critical in meeting these health challenges. Additionally, the pharmaceutical industry's focus on precision medicine tailored to genetic profiles is pushing the boundaries of traditional drug discovery, further fueling the demand for advanced technologies.

Key Insights:

Market Growth: Understand the significant growth trajectory of the Small Molecule Drugs Discovery Technologies segment, which is expected to reach US$92.7 Billion by 2030 with a CAGR of a 8.4%. The Biologics Discovery Technologies segment is also set to grow at 9.6% CAGR over the analysis period.
Regional Analysis: Gain insights into the U.S. market, estimated at $18.7 Billion in 2023, and China, forecasted to grow at an impressive 10.6% CAGR to reach $19.0 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

Detailed Market Analysis: Access a thorough analysis of the Global Drug Discovery Technologies Market, covering all major geographic regions and market segments.
Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Drug Discovery Technologies Market.
Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

How is the Global Drug Discovery Technologies Market expected to evolve by 2030?
What are the main drivers and restraints affecting the market?
Which market segments will grow the most over the forecast period?
How will market shares for different regions and segments change by 2030?
Who are the leading players in the market, and what are their prospects?

Report Features:

Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
Company Profiles: Coverage of major players such as Agilent Technologies, Inc., Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., and more.
Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 129 Featured):

Agilent Technologies, Inc.
Beckman Coulter, Inc.
Bio-Rad Laboratories, Inc.
Alnylam Pharmaceuticals, Inc.
Antares Pharma, Inc.
Ambrx, Inc.
ActivX Biosciences, Inc.
Alembic Pharmaceuticals Limited
BioVision, Inc.
Acadia Pharmaceuticals, Inc.
Beactica Therapeutics AB
Atomwise, Inc.
BeiGene LTD.
ATXA Therapeutics
Bayer Pharmaceuticals

I. METHODOLOGYII. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Influencer Market Insights
World Market Trajectories
Drug Discovery Technologies - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
A Prelude to Drug Discovery Technologies
Global Market Analysis and Prospects
Global Drug Discovery Technologies Market Set to Witness Rapid Growth
Regional Market Analysis
Market Analysis based on Application
Market Analysis based on End-User
Competition
Recent Market Activity

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

Late-Stage Drug Failures Drives Demand for Drug Discovery Technolgies
Factors Leading to Failure of Drugs in Phase III Clinical Trials: Percentage Breakdown of Number of Cases for Efficacy, Pharmacokinetics, Toxicity and Others
Cell-based Assays Play a Critical Role in Drug Discovery
Major Types of Cell-Based HTS Assays for Drug Screening
High-Content Screening (HCS) - An Expanding Technology in Cell-Based Assays
High Content Screening - Key Application Areas
Technology Advances in Drug Discovery Processes
Increased Demand of Biochips in Drug Discovery to Drive Market Growth
Increased Demand for Personalized Medicine to Drive Drug Discovery Technologies Market
Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019, 2021, 2023 and 2025
Proteomics and Genomics Drive Opportunities for Drug Discovery Technologies
Proteomics Profiling to Expedite Drug Discovery
Other Applications of Proteomics in Drug Discovery
New Proteomics Technique to Aid Drug Screening & Biomarker Discovery
Proteomic Approaches Gain Prominence in Cancer Drug Discovery
Proteomics Technologies Used in Cancer Drug Discovery and Development
Role of Proteomics in Oncology Biomarker Discovery
Bioinformatics Tools along with Proteomics Accelerate the Process of Pathway Prediction
Using AI in Drug Discovery: The Latest Market Research
High-throughput Screening (HTS) - A Key Drug Discovery Technology
HTS: Making Use of a Smarter Approach to Hit Discovery
Emerging Technologies in Drug Discovery and Development
Targeted Drug Development and Discovery
Significance of Advanced Clinical Sequencing for Drug Developers
Metabolomics: An Emerging Trend in Drug Discovery
Impact of ADME-Tox Screening on New Drug Discovery
Phase-I Clinical Trial Failures Before and After the Advent of Preclinical ADME/Pharmacokinetics
Pharma Industry Renews Focus on Cost Optimization
China and India: Hot Spots for R&D Investment
Omics Technology to Witness Rapid Growth
Adoption of Omics-based Technologies
Increasing Demand for 3D Cell Culture in Drug Discovery

4. GLOBAL MARKET PERSPECTIVE

TABLE 1: World Recent Past, Current & Future Analysis for Drug Discovery Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 2: World Historic Review for Drug Discovery Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 3: World 16-Year Perspective for Drug Discovery Technologies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Small Molecule Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 5: World Historic Review for Small Molecule Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 6: World 16-Year Perspective for Small Molecule Drugs by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Biologics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 8: World Historic Review for Biologics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 9: World 16-Year Perspective for Biologics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for High Throughput Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 11: World Historic Review for High Throughput Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 12: World 16-Year Perspective for High Throughput Screening by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 13: World Recent Past, Current & Future Analysis for Biochips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 14: World Historic Review for Biochips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 15: World 16-Year Perspective for Biochips by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for Bioinformatics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 17: World Historic Review for Bioinformatics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 18: World 16-Year Perspective for Bioinformatics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 19: World Recent Past, Current & Future Analysis for Pharmacogenomics & Pharmacogenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 20: World Historic Review for Pharmacogenomics & Pharmacogenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 21: World 16-Year Perspective for Pharmacogenomics & Pharmacogenetics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 22: World Recent Past, Current & Future Analysis for Nanotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 23: World Historic Review for Nanotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 24: World 16-Year Perspective for Nanotechnology by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 25: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 26: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 27: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 28: World Recent Past, Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 29: World Historic Review for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 30: World 16-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 31: World Recent Past, Current & Future Analysis for Pharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 32: World Historic Review for Pharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 33: World 16-Year Perspective for Pharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 34: World Recent Past, Current & Future Analysis for Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 35: World Historic Review for Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 36: World 16-Year Perspective for Biotechnology Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 37: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 38: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 39: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 40: World Drug Discovery Technologies Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

UNITED STATES

Drug Discovery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)

CANADA

JAPAN

Drug Discovery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)

CHINA

Drug Discovery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)

EUROPE

Drug Discovery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)

FRANCE

Drug Discovery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)

GERMANY

Drug Discovery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)

ITALY

UNITED KINGDOM

Drug Discovery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)

REST OF EUROPE

ASIA-PACIFIC

Drug Discovery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)

REST OF WORLDIV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Agilent Technologies, Inc.
Beckman Coulter, Inc.
Bio-Rad Laboratories, Inc.
Alnylam Pharmaceuticals, Inc.
Antares Pharma, Inc.
Ambrx, Inc.
ActivX Biosciences, Inc.
Alembic Pharmaceuticals Limited
BioVision, Inc.
Acadia Pharmaceuticals, Inc.
Beactica Therapeutics AB
Atomwise, Inc.
BeiGene LTD.
ATXA Therapeutics
Bayer Pharmaceuticals

Table Information

Report Attribute	Details
No. of Pages	486
Published	November 2024
Forecast Period	2023 - 2030
Estimated Market Value ( USD ) in 2023	$ 69.1 Billion
Forecasted Market Value ( USD ) by 2030	$ 124.2 Billion
Compound Annual Growth Rate	8.7%
Regions Covered	Global

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€5184EUR$5,450USD£4,364GBP
1 - 10 USER LICENSE PDF	The product is a PDF.	This is a 1-10 user license, allowing up to ten users have access to the product.	€9850EUR$10,355USD£8,292GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€15552EUR$16,350USD£13,092GBP

Key Insights:

Why You Should Buy This Report:

Key Questions Answered:

Report Features:

Select Competitors (Total 129 Featured):

Table of Contents

Companies Mentioned (Partial List)

Table Information

Related Topics

Related Reports

Drug Discovery Technologies Market by Technology, Drug Type, End User - Global Forecast 2025-2030

Drug Discovery Technologies Global Market Opportunities and Strategies to 2033

Drug Discovery Technologies Global Market Report 2024

Drug Discovery Technologies Market Forecast to 2029

Drug Discovery Technology Market Report: Trends, Forecast and Competitive Analysis to 2030